ВПЛИВ МОЛЕКУЛЯРНОГО ФЕНОТИПУ ПУХЛИНИ НА ВИЖИВАНІСТЬ ХВОРИХ НА РАК ШЛУНКА ПІСЛЯ РАДИКАЛЬНОГО ХІРУРГІЧНОГО ВТРУЧАННЯ

The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken in...

Full description

Saved in:
Bibliographic Details
Date:2023
Main Authors: Dumanskyi, Yu.V., Kirkilevskyi, S.I., Sulaeva, O.M., Polyasnyi, V.O., Mashukov, A.O., Kovalevska, L.A., Yarema, R.R., Ogorchak, M.A.
Format: Article
Language:English
Published: PH Akademperiodyka 2023
Subjects:
Online Access:https://exp-oncology.com.ua/index.php/Exp/article/view/2022-44-4-1
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Experimental Oncology

Institution

Experimental Oncology
Description
Summary:The strategy for the treatment of gastric cancer (GC), in particular the use of the extended surgical interventions in different countries varies. The different proportion of specific molecular GC subtypes in various populations frequently is not taken into account for comparing treatment outcomes. This pilot study analyzes the association of survival of GC patients after the extended combined surgical interventions depending on the molecular subtype of the tumors. An improved survival for patients with diffuse cancer types (p53–, VEGFR+, HER2/neu+, Ki-67+ phenotype) was demonstrated. The authors propose their point of view on the importance of recognizing GC molecular heterogeneity.